RT Journal Article SR Electronic T1 Tackling Quality—It's Never a Level Playing Field JF Neurology: Clinical Practice FD Lippincott Williams & Wilkins SP 270 OP 272 DO 10.1212/CPJ.0000000000001153 VO 12 IS 3 A1 Cabaniss, Brian A1 Williams, Korwyn A1 Ward, Meghan A1 Cremeen, Desiree A1 Nair, Kavita YR 2022 UL http://cp.neurology.org/content/12/3/270.abstract AB The American Academy of Neurology (AAN) has recently proposed 3 outcome metrics crafted to be both broadly applicable across neurologic diseases and to function as potential tools to facilitate quality improvement. These measures should be of interest to physicians and payers due to the increasing linkage of reimbursement to quality care. However, the use of quality measures cannot exist in a vacuum as external factors outside of physician control can negatively affect these metrics. The original Centers for Medicare and Medicaid (CMS) value-based programs illustrate the necessity for iterative review and revision of outcome metrics to allow for risk adjustment to avoid unjust penalties. Accordingly, at this time, the Neurology Outcome Measurement Set is not suitable for inclusion in a quality payment program.